Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.
$144.02M
Dr. Osvaldo Flores Ph.D.
170.00
Philadelphia, PA
Jun 18, 2021
-0.84
$-2.02
2.16
10.62
-6,434.23%
-1.04
-0.01
0.61
68.87
10.62
-31.55%
-65.37%
Similar stocks (13)
Blueprint Medicines Corporation
BPMC
Edgewise Therapeutics, Inc.
EWTX
Keros Therapeutics, Inc.
KROS
Relay Therapeutics, Inc.
RLAY
Cullinan Oncology, Inc.
CGEM
Erasca, Inc.
ERAS
Stoke Therapeutics, Inc.
STOK
C4 Therapeutics, Inc.
CCCC
Monte Rosa Therapeutics, Inc.
GLUE
Nkarta, Inc.
NKTX
Generation Bio Co.
GBIO
Passage Bio, Inc.
PASG
Kezar Life Sciences, Inc.
KZR
ETF Exposure (21)
iShares Micro-Cap ETF
IWC
0.0174%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.00494%
Schwab U.S. Small-Cap ETF
SCHA
0.0031797496%
iShares Russell 2000 ETF
IWM
0.00224%
ProShares Ultra Russell2000
UWM
9.78401048814717e-4%
ProShares UltraPro Russell2000
URTY
4.8241525868269374e-4%
ProShares Hedge Replication ETF
HDG
4.084347814098411e-4%
Schwab U.S. Broad Market ETF
SCHB
3.723209e-4%
iShares Russell 3000 ETF
IWV
0.0001%
Dimensional U.S. Core Equity 2 ETF
DFAC
3.198e-5%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (13)
Blueprint Medicines Corporation
BPMC
Edgewise Therapeutics, Inc.
EWTX
Keros Therapeutics, Inc.
KROS
Relay Therapeutics, Inc.
RLAY
Cullinan Oncology, Inc.
CGEM
Erasca, Inc.
ERAS
Stoke Therapeutics, Inc.
STOK
C4 Therapeutics, Inc.
CCCC
Monte Rosa Therapeutics, Inc.
GLUE
Nkarta, Inc.
NKTX
Generation Bio Co.
GBIO
Passage Bio, Inc.
PASG
Kezar Life Sciences, Inc.
KZR
ETF Exposure (21)
iShares Micro-Cap ETF
IWC
0.0174%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.00494%
Schwab U.S. Small-Cap ETF
SCHA
0.0031797496%
iShares Russell 2000 ETF
IWM
0.00224%
ProShares Ultra Russell2000
UWM
9.78401048814717e-4%
ProShares UltraPro Russell2000
URTY
4.8241525868269374e-4%
ProShares Hedge Replication ETF
HDG
4.084347814098411e-4%
Schwab U.S. Broad Market ETF
SCHB
3.723209e-4%
iShares Russell 3000 ETF
IWV
0.0001%
Dimensional U.S. Core Equity 2 ETF
DFAC
3.198e-5%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Extended Market Index Fund
VXF
0%